Skip to main content

Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk

Date: Wednesday, May 27, 2020

Description: In these unprecedented times, patients, especially the elderly and those with a history of coronary artery disease, are at particular risk of adverse outcomes with COVID-19. There has been long-term recognition that viral infections may lead to an increase in risk for myocardial infarction (MI).

This will be a discussion focusing on:

  • The role that viral infections play in vascular inflammation and plaque rupture 
  • How to identify those patients at increased risk for a cardiovascular event with viral respiratory infection 
  • Tools to monitor therapeutic response


Penn, Marc S., MD
Co-Founder and Chief Medical Officer, Cleveland HeartLab, Quest Diagnostics